Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Johansson, Maria H; Taylor, Mesha A; Jagodic, Maja et al. (2006) Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice. J Immunol 177:7923-9
Gao, Ning; Dang, Tam; Dunnick, Wesley A et al. (2005) Receptors and counterreceptors involved in NK-B cell interactions. J Immunol 174:4113-9
Mooney, Jill M; Klem, Jennifer; Wulfing, Christoph et al. (2004) The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression. J Immunol 173:3953-61
Yuan, Dorothy; Bibi, Rula; Dang, Tam (2004) The role of adjuvant on the regulatory effects of NK cells on B cell responses as revealed by a new model of NK cell deficiency. Int Immunol 16:707-16
Klem, Jennifer; Verrett, Pamela C; Kumar, Vinay et al. (2002) 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J Immunol 169:55-62
Taylor, Mesha Austin; Ward, Brant; Schatzle, John D et al. (2002) Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur J Immunol 32:793-9
Morris, Margaret A; Liu, Jingxuan; Arora, Veera et al. (2002) B6 strain Ly49I inhibitory gene expression on T cells in FVB.Ly49IB6 transgenic mice fails to prevent normal T cell functions. J Immunol 169:3661-6
Morris, Margaret A; Koulich, Elena; Liu, Jingxuan et al. (2002) Definition of additional functional ligands for Ly49I(B6) using FVBLy49I(B6) transgenic mice and B6 natural killer cell effectors. Transplantation 74:1449-54
Murphy, W J; Koh, C Y; Raziuddin, A et al. (2001) Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 181:279-89
Boles, K S; Stepp, S E; Bennett, M et al. (2001) 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol Rev 181:234-49

Showing the most recent 10 out of 43 publications